BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torres E, Delgado M, Valiente A, Pascual Á, Rodríguez-baño J. Impact of borderline minimum inhibitory concentration on the outcome of invasive infections caused by Enterobacteriaceae treated with β-lactams: a systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 2015;34:1751-8. [DOI: 10.1007/s10096-015-2408-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Chastain DB, White BP, Cretella DA, Bland CM. Is It Time to Rethink the Notion of Carbapenem-Sparing Therapy Against Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Bloodstream Infections? A Critical Review. Ann Pharmacother 2018;52:484-92. [PMID: 29239220 DOI: 10.1177/1060028017748943] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Grillon A, Chabaud A, Zambardi G, Caniaux I, Jehl F. Breakpoint to MIC quotient: A parameter to rapidly evaluate the in vitro bactericidal activity of β-lactams on Enterobacteriaceae. Int J Antimicrob Agents 2019;53:674-7. [PMID: 30716447 DOI: 10.1016/j.ijantimicag.2019.01.013] [Reference Citation Analysis]
3 Grillon A, Schramm F, Kleinberg M, Jehl F. Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies. PLoS One 2016;11:e0156690. [PMID: 27257956 DOI: 10.1371/journal.pone.0156690] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
4 Delgado-Valverde M, Torres E, Valiente-Mendez A, Almirante B, Gómez-Zorrilla S, Borrell N, Corzo JE, Gurgui M, Almela M, García-Álvarez L, Fontecoba-Sánchez MC, Martínez-Martínez L, Cantón R, Praena J, Causse M, Gutiérrez-Gutiérrez B, Roberts JA, Farkas A, Pascual Á, Rodríguez-Baño J; REIPI/GEIH-SEIMC BACTERAEMIA-MIC Group. Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project. J Antimicrob Chemother 2016;71:521-30. [PMID: 26538507 DOI: 10.1093/jac/dkv362] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
5 Baquer F, Ali Sawan A, Auzou M, Grillon A, Jaulhac B, Join-Lambert O, Boyer PH. Broth Microdilution and Gradient Diffusion Strips vs. Reference Agar Dilution Method: First Evaluation for Clostridiales Species Antimicrobial Susceptibility Testing. Antibiotics (Basel) 2021;10:975. [PMID: 34439025 DOI: 10.3390/antibiotics10080975] [Reference Citation Analysis]
6 O’donnell JN, Miglis CM, Lee JY, Tuvell M, Lertharakul T, Scheetz MH. Carbapenem susceptibility breakpoints, clinical implications with the moving target. Expert Review of Anti-infective Therapy 2016;14:389-401. [DOI: 10.1586/14787210.2016.1159131] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]